Utah Medical Products, Inc. (UTMD)
69.16
-1.94
(-2.73%)
USD |
NASDAQ |
Sep 08, 16:00
67.99
-1.17
(-1.69%)
Pre-Market: 20:00
Utah Medical Products Total Liabilities (Quarterly) : 2.539M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.539M |
| March 31, 2026 | 4.009M |
| December 31, 2025 | 3.274M |
| September 30, 2025 | 3.723M |
| June 30, 2025 | 3.269M |
| March 31, 2025 | 5.472M |
| December 31, 2024 | 5.111M |
| September 30, 2024 | 5.497M |
| June 30, 2024 | 5.98M |
| March 31, 2024 | 7.699M |
| December 31, 2023 | 7.145M |
| September 30, 2023 | 7.541M |
| June 30, 2023 | 8.714M |
| March 31, 2023 | 9.752M |
| December 31, 2022 | 9.62M |
| September 30, 2022 | 10.23M |
| June 30, 2022 | 8.678M |
| March 31, 2022 | 10.64M |
| December 31, 2021 | 8.498M |
| September 30, 2021 | 9.772M |
| June 30, 2021 | 9.429M |
| March 31, 2021 | 9.505M |
| December 31, 2020 | 8.923M |
| September 30, 2020 | 8.657M |
| June 30, 2020 | 8.258M |
| Date | Value |
|---|---|
| March 31, 2020 | 8.808M |
| December 31, 2019 | 8.694M |
| September 30, 2019 | 9.108M |
| June 30, 2019 | 9.449M |
| March 31, 2019 | 12.88M |
| December 31, 2018 | 10.78M |
| September 30, 2018 | 10.32M |
| June 30, 2018 | 13.68M |
| March 31, 2018 | 14.50M |
| December 31, 2017 | 14.62M |
| September 30, 2017 | 9.478M |
| June 30, 2017 | 8.692M |
| March 31, 2017 | 9.629M |
| December 31, 2016 | 7.34M |
| September 30, 2016 | 10.14M |
| June 30, 2016 | 9.972M |
| March 31, 2016 | 11.56M |
| December 31, 2015 | 9.527M |
| September 30, 2015 | 11.80M |
| June 30, 2015 | 11.74M |
| March 31, 2015 | 11.53M |
| December 31, 2014 | 16.52M |
| September 30, 2014 | 18.06M |
| June 30, 2014 | 19.32M |
| March 31, 2014 | 19.96M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Abbott Laboratories | 57.45B |
| AngioDynamics, Inc. | 96.34M |
| Alphatec Holdings, Inc. | 779.49M |
| AtriCure, Inc. | 160.21M |
| Baxter International, Inc. | 13.61B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 124.57M |
| Shareholders Equity (Quarterly) | 122.03M |
| Debt to Equity Ratio | 0.0016 |
| Current Ratio | 48.62 |
| Net Debt Paydown Yield | 0.01% |